Picture of medmix AG logo

MEDX — medmix AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Medmix AG Targets 5% To 7% Growth In Revenue In 2023

Feb 22 (Reuters) - medmix AG  MEDX.S :
    * TARGETS 5% TO 7% GROWTH IN REVENUE IN 2023
    * MEDMIX - DUE TO NEW PRODUCTION FACILITIES IN SPAIN AND US
AND
PLANNED INVESTMENTS IN RESEARCH AND DEVELOPMENT, MEDMIX
INDICATES AN ELEVATED CAPITAL EXPENDITURE LEVEL AT 14% OF
REVENUE IN 2023
    * FOR FINANCIAL YEAR OF 2022, MEDMIX PROPOSES TO PAY A
DIVIDEND OF
CHF 0.50 PER SHARE

Further company coverage:  MEDX.S 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on medmix AG

See all news